✦ LIBER ✦

Identification and Characterization of the MDR1 Promoter-Enhancing Factor 1 (MEF1) in the Multidrug Resistant HL60/VCR Human Acute Myeloid Leukemia Cell Line †

✍ Scribed by Ogretmen, Besim; Safa, Ahmad R.

Book ID: 120347048
Publisher: American Chemical Society
Year: 2000
Tongue: English
Weight: 202 KB
Volume: 39
Category: Article
ISSN: 0006-2960
DOI: 10.1021/bi991943f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Presence of WT1 in nuclear messenger RNP

Presence of WT1 in nuclear messenger RNP particles in the human acute myeloid leukemia cell lines HL60 and K562

✍ Avril A. Morrison; Michael R. Ladomery 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 163 KB

The role of interferon-γ in induction of

The role of interferon-γ in induction of differentiation of human myeloid leukemia cell lines, ML-1 and HL-60

✍ Makiko Takei; Ken Takeda; Kunio Konno 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Enhancement of mdr1 gene expression by t

Enhancement of mdr1 gene expression by transforming growth factor-β1 in the new adriamycin-resistant human leukemia cell line ME-F2/ADM

✍ Utsunomiya, Y; Hasegawa, H; Yanagisawa, K; Fujita, S 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 667 KB

Increment of the Cyclin D1 mRNA Level in

Increment of the Cyclin D1 mRNA Level in TPA-Treated Three Human Myeloid Leukemia Cell Lines: HEL, CMK, and HL-60 Cells

✍ N. Akiyama; H. Sasaki; O. Katoh; T. Sato; H. Hirai; Y. Yazaki; T. Sugimura; M. T 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 481 KB

Resistance to 1,25D-induced differentiat

Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor

✍ Edward Garay; Robert Donnelly; Xuening Wang; George P. Studzinski 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

## Abstract The anti‐neoplastic effects of 1,25‐dihydroxyvitamin D~3~ (1,25D) are well documented in numerous tumor cell systems and animal models of cancer. However, despite this pre‐clinical success, the clinical use of 1,25D is currently impeded by the dose‐limiting hypercalcemia, and the risk o